Cambridge Investment Research Advisors’s Invesco IVZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Buy
54,172
+16,027
+42% +$419K ﹤0.01% 1938
2025
Q4
$1M Buy
38,145
+10,040
+36% +$245K ﹤0.01% 2092
2025
Q3
$645K Buy
28,105
+1,288
+5% +$26.7K ﹤0.01% 2437
2025
Q2
$423K Sell
26,817
-9,622
-26% -$138K ﹤0.01% 2692
2025
Q1
$553K Buy
36,439
+398
+1% +$6.79K ﹤0.01% 2335
2024
Q4
$630K Buy
36,041
+3,583
+11% +$63.8K ﹤0.01% 2241
2024
Q3
$570K Buy
32,458
+3,926
+14% +$64.5K ﹤0.01% 2305
2024
Q2
$427K Sell
28,532
-43,543
-60% -$670K ﹤0.01% 2427
2024
Q1
$1.2M Buy
72,075
+37,666
+109% +$608K ﹤0.01% 1611
2023
Q4
$614K Sell
34,409
-2,175
-6% -$31.4K ﹤0.01% 2026
2023
Q3
$531K Sell
36,584
-11,176
-23% -$180K ﹤0.01% 2035
2023
Q2
$803K Sell
47,760
-159,881
-77% -$2.57M ﹤0.01% 1764
2023
Q1
$3.4M Buy
207,641
+171,437
+474% +$3.06M 0.02% 816
2022
Q4
$651K Sell
36,204
-1,134
-3% -$19.4K ﹤0.01% 1820
2022
Q3
$512K Buy
37,338
+3,283
+10% +$55.4K ﹤0.01% 1916
2022
Q2
$549K Sell
34,055
-14,799
-30% -$280K ﹤0.01% 1892
2022
Q1
$1.13M Sell
48,854
-4,451
-8% -$98.7K 0.01% 1490
2021
Q4
$1.23M Sell
53,305
-5,103
-9% -$124K 0.01% 1442
2021
Q3
$1.41M Sell
58,408
-20,019
-26% -$501K 0.01% 1295
2021
Q2
$2.1M Sell
78,427
-379,558
-83% -$10.3M 0.01% 1086
2021
Q1
$11.6M Buy
457,985
+385,875
+535% +$8.65M 0.06% 292
2020
Q4
$1.26M Buy
72,110
+12,304
+21% +$189K 0.01% 1170
2020
Q3
$682K Buy
59,806
+31,583
+112% +$335K ﹤0.01% 1411
2020
Q2
$304K Sell
28,223
-280
-1% -$2.51K ﹤0.01% 1873
2020
Q1
$259K Sell
28,503
-23,667
-45% -$360K ﹤0.01% 1767
2019
Q4
$938K Buy
52,170
+8,520
+20% +$145K 0.01% 1180
2019
Q3
$739K Buy
43,650
+15,717
+56% +$278K 0.01% 1257
2019
Q2
$572K Sell
27,933
-3,600
-11% -$74.7K 0.01% 1338
2019
Q1
$609K Buy
31,533
+1,982
+7% +$37.1K 0.01% 1351
2018
Q4
$495K Buy
29,551
+698
+2% +$14K 0.01% 1329
2018
Q3
$660K Buy
28,853
+6,224
+28% +$156K 0.01% 1280
2018
Q2
$601K Sell
22,629
-1,018
-4% -$29.3K 0.01% 1307
2018
Q1
$757K Buy
23,647
+7,732
+49% +$267K 0.01% 1099
2017
Q4
$582K Buy
15,915
+1,604
+11% +$58K 0.01% 1235
2017
Q3
$501K Buy
14,311
+1,356
+10% +$46.3K 0.01% 1256
2017
Q2
$456K Sell
12,955
-207
-2% -$6.75K 0.01% 1257
2017
Q1
$403K Buy
13,162
+1,434
+12% +$44.8K 0.01% 1184
2016
Q4
$356K Buy
11,728
+630
+6% +$19.4K 0.01% 1186
2016
Q3
$347K Sell
11,098
-6,275
-36% -$184K 0.01% 1220
2016
Q2
$444K Buy
17,373
+2,354
+16% +$69.9K 0.01% 982
2016
Q1
$462K Buy
15,019
+1,639
+12% +$47.3K 0.01% 939
2015
Q4
$448K Sell
13,380
-278
-2% -$9.11K 0.01% 900
2015
Q3
$427K Buy
13,658
+2,330
+21% +$82.9K 0.01% 836
2015
Q2
$425K Buy
11,328
+825
+8% +$33K 0.01% 891
2015
Q1
$417K Sell
10,503
-607
-5% -$23.7K 0.01% 885
2014
Q4
$439K Sell
11,110
-504
-4% -$19.9K 0.01% 841
2014
Q3
$459K Buy
11,614
+3
+0% +$118 0.01% 874
2014
Q2
$438K Buy
11,611
+1,474
+15% +$53.3K 0.02% 817
2014
Q1
$375K Buy
+10,137
New +$351K 0.01% 851

Other funds holding IVZ

Cambridge Investment Research Advisors's IVZ Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Invesco (IVZ) stake by 42% in Q1 2026, buying an estimated $419K and bringing the position to 54,172 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

Cambridge Investment Research Advisors first reported a position in IVZ in Q1 2014 and has held it in 49 quarters since. The position peaked at $11.6M in Q1 2021. 631 funds tracked by Wall St. Rank hold IVZ as of Q1 2026.

  • Cambridge Investment Research Advisors held 54,172 shares of Invesco worth $1.32M as of Q1 2026.
  • Cambridge Investment Research Advisors bought 16,027 Invesco shares in Q1 2026, an estimated $419K.
  • Invesco made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1938 holding.
  • Cambridge Investment Research Advisors first reported a position in Invesco in Q1 2014 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's Invesco position peaked at $11.6M in Q1 2021.
  • 631 funds tracked by Wall St. Rank held Invesco as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.